(Q40608630)
Statements
1 reference
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer (English)
1 reference
E Vokes
1 reference
J Nemunaitis
1 reference
F Khuri
1 reference
I Ganly
1 reference
J Arseneau
1 reference
M Posner
1 reference
J Kuhn
1 reference
T McCarty
1 reference
S Landers
1 reference
A Blackburn
1 reference
L Romel
1 reference
B Randlev
1 reference
S Kaye
1 reference
D Kirn
1 reference
1 January 2001
1 reference
1 reference
Identifiers
1 reference